Clinical Trials Directory

Trials / Completed

CompletedNCT03554720

RSA of the ATTUNE Knee System: RCT Comparing Traditional Vs Enhanced-Fixation Device Designs

Radiostereometric Analysis (RSA) of the ATTUNE Knee System: A Randomized Controlled Trial Comparing Traditional Versus Enhanced-Fixation Device Designs

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Canadian Radiostereometric Analysis Network · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Accepted

Summary

The principal objective of this study is to compare migration patterns between the Attune and Attune S+ PS knee systems using model-based RSA over the first 2 post-operative years. Secondary objectives include; comparison of 2-year migration values against published thresholds for adequate short-term fixation, quantify changes in functional and health status of subjects following surgery and compare between study groups, and assess occurrences of complications following surgery.

Detailed description

This is a multi-centre, randomized controlled trial of patients undergoing posterior-stabilized total knee arthroplasty. In this study, the investigators propose to randomize 50 subjects to receive either the standard Attune PS TKA (n=25) or the enhanced fixation Attune S+ PS TKA (n=25) and follow them for a period of 2 years post-operatively. The primary outcome of the study will be stability of fixation of the tibial baseplate as measured by model-based RSA. Secondary outcomes will be to determine the functionality of patients after surgery using self-reported questionnaires.

Conditions

Interventions

TypeNameDescription
DEVICEATTUNE PS KneeThe ATTUNE PS Knee is the standard implants.
DEVICEATTUNE S+ PS KneeThe ATTUNE S+ PS Knee is the enhanced fixation.

Timeline

Start date
2018-07-04
Primary completion
2021-11-03
Completion
2024-01-15
First posted
2018-06-13
Last updated
2024-01-17

Locations

2 sites across 1 country: Canada

Regulatory

Source: ClinicalTrials.gov record NCT03554720. Inclusion in this directory is not an endorsement.